There is increasing evidence that suggests a strong infiltration of T cells, especially CD8+ T cells, into the TME correlates with a good prognosis in many types of cancer, and this has implications for the success of active cancer immunotherapy [41,42]. The gene discussed is CD8A; the disease is cancer.